Karcinom prostaty (PSA) — Prostate Screening

MEDEOR's Karcinom prostaty package is a self-pay prostate-screening blood test for men in Přerov, measuring PSA (prostate-specific antigen) including the free/total ratio. It supports early detection and monitoring of prostate conditions, analysed on-site, with no referral needed.

Prostate-specific antigen (PSA) is a protein produced by the prostate gland, and its blood level is the principal marker used to screen for and monitor prostate conditions, including benign enlargement and prostate cancer. MEDEOR's Karcinom prostaty package gives men in Přerov direct self-pay access. The package measures total PSA and typically the free-PSA fraction, allowing calculation of the free/total PSA ratio — a refinement that helps distinguish benign prostatic enlargement from changes that warrant urological investigation, reducing unnecessary follow-up. PSA testing is widely used both for periodic screening in men over 50 (or earlier with a family history) and for monitoring known prostate conditions over time. Samples are processed at MEDEOR's accredited Přerov laboratory with routine results generally available by the next working day. No referral is required. The laboratory team can advise on whether the PSA level and free/total ratio fall within expected ranges and whether urology follow-up is appropriate. Results should be interpreted in context, as several non-cancer factors can also raise PSA.